Luis Soruco
Endocrinology, Diabetes & Metabolism · Arlington Heights, ILNPI 1013065556
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $18,963 of the $26,785 with a category attached, or 70.8%. Lilly USA, LLC accounts for 76.1% of it on its own, with 31 other manufacturers making up the rest. Reporting peaked in 2019 at $15,535 and has fallen 99.9% since, to $14 in 2022.
Across 206 payments — averaging $130.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$20K
- Boehringer Ingelheim$4K
- Novo Nordisk$342
- AstraZeneca$203
- Abbott$174
- Shire North American Group Inc$170
- plus $1K from 26 others
Across 21 payments — averaging $1432.41 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi US Services Inc.$27K
- Lexicon Pharmaceuticals, Inc.$3K
- Boehringer Ingelheim$383
- Boehringer Ingelheim Pharma GmbH & Co.kg$147
What the payments were for
- Consulting fees$2,92511%
- Speaking & faculty fees$18,96371%
- Travel & lodging$1,4705%
- Food & beverage$3,42013%
- Education$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 36 | $20,390 |
| Boehringer Ingelheim | 37 | $4,240 |
| Novo Nordisk | 22 | $342 |
| AstraZeneca(2 entities) | 11 | $203 |
| Abbott | 16 | $174 |
| Shire North American Group Inc | 8 | $170 |
| Amgen(2 entities) | 8 | $162 |
| Sanofi-aventis U.S. LLC | 10 | $156 |
| Merck | 9 | $120 |
| Amneal Pharmaceuticals LLC | 5 | $94 |
| Tandem Diabetes Care, Inc. | 5 | $87 |
| Dexcom, Inc. | 5 | $81 |
| Mannkind Corporation | 5 | $58 |
| Johnson & Johnson | 4 | $57 |
| Lifescan, Inc. | 2 | $47 |
| Medtronic | 2 | $46 |
| AbbVie | 2 | $43 |
| Radius Health, Inc. | 2 | $36 |
| BD | 1 | $32 |
| Corcept Therapeutics | 2 | $31 |
| Vivus LLC | 2 | $27 |
| OPKO Pharmaceuticals, LLC | 2 | $25 |
| Amarin Pharma, Inc. | 1 | $21 |
| Eisai Inc. | 1 | $21 |
| Companion Medical, Inc. | 1 | $19 |
| Antares Pharma, Inc. | 1 | $18 |
| Recordati_rare_diseases_inc. | 1 | $17 |
| Insulet Corporation | 1 | $16 |
| Valeritas, Inc. | 1 | $15 |
| IBSA Pharma Inc. | 1 | $13 |
| Ultragenyx Pharmaceutical Inc. | 1 | $12 |
| Mission Pharmacal Company | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$23,647
How this compares
$26,785 in reported general payments places this provider in the 85th percentile of 347 endocrinology, diabetes & metabolism providers in Illinois.
See all endocrinology, diabetes & metabolism providers in Illinois →
Other endocrinology, diabetes & metabolism in Arlington Heights
- Daniel SoArlington Heights$283K
- Mario ChanArlington Heights$32K
- Zubair IlyasArlington Heights$16K
- Wahid KassarChicago$884K
- Anthony PickLake Forest$665K
- Babak PazookiJoliet$582K
- Ammar BayrakdarEvergreen Park$517K
- George BakrisChicago$403K
- Terrence SwadeLombard$369K
- Wenyu HuangChicago$341K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.